Global Direct-to-Consumer (DTC) Genetic Testing Market, By Service (Diagnostic Screening, Prenatal, New-born Screening, Pre-Implantation Diagnosis and Relationship Testing), Test Type (Carrier Testing, Predictive Testing, Ancestry and Relationship Testing, Nutrigenomics Testing and Others), Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips and Whole Genome Sequencing (WGS)), Product Type (Ancestry, Health and Wellness and Entertainment), Business Model (Genome Data Bank Material Model, Individual Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model and Restricted Trait Tests Model), End User (Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centres, Home Care, Cosmetics and Others), Sales Channel (Online Sales, OTC Sales and Doctor's Office)) - Industry Trends and Forecast to 2030.
Direct-to-Consumer (DTC) Genetic Testing Market Analysis and Size
Direct-to-consumer (DTC) testing can also be known as direct access testing, which allows customers to order laboratory tests directly from a laboratory without necessarily having to work with their healthcare provider. Major factors that are expected to boost the growth of the direct-to-consumer (DTC) genetic testing market in the forecast period are the rise in public alertness. Furthermore, the increase in the income level in the advancing countries is further anticipated to propel the growth of the direct-to-consumer (DTC) genetic testing market.
Data Bridge Market Research analyses that the Direct-to-consumer (DTC) genetic testing market was valued at USD 1,550.51 million in 2022 and is further estimated to reach USD 3,880.35 million by 2030, and is expected to grow at a CAGR of 12.15% during the forecast period of 2023 to 2030. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Direct-to-Consumer (DTC) Genetic Testing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Year
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Service (Diagnostic Screening, Prenatal, New-born Screening, Pre-Implantation Diagnosis and Relationship Testing), Test Type (Carrier Testing, Predictive Testing, Ancestry and Relationship Testing, utrigenomics Testing and Others), Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips and Whole Genome Sequencing (WGS)), Product Type (Ancestry, Health and Wellness and Entertainment), Business Model (Genome Data Bank Material Model, Individual Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model and Restricted Trait Tests Model), End User (Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centres, Home Care, Cosmetics and Others), Sales Channel (Online Sales, OTC Sales and Doctor's Office)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
EasyDNA (U.S.), Ancestry (U.S.), 23andMe, Inc. (U.S.), Color Health, Inc.(U.S.), Genesis HealthCare (U.S.), Full Genomes Corporation, Inc.(U.S.), Helix OpCo LLC (U.S.), Living DNA Ltd (U.K.), Mapmygenome (India), GenomeWeb (U.S.), Gene by Gene, Ltd. (U.S.), MyHeritage Ltd. (Israel), 10x Genomics (U.S.), Dante Labs, Inc. (U.S.), 24Genetics (Spain), Laboratory Corporation of America Holdings (U.S.), Myriad Genetics, Inc. (U.S.), Quest Diagnostics Incorporated (U.S.) and Uniogen Oy (turkey), among other
|
|
Market Opportunities
|
|
Market Definition
The global direct-to-consumer (DTC) genetic testing market refers to markets where genetic testing services and products are sold directly to consumers without the involvement of medical professionals or intermediaries. DTC genetic testing allows individuals to access their genetic information and analyze it for a variety of purposes, including ancestry tracing, health risk assessment, and personalized medicine. This market includes companies that provide genetic testing kits, online test ordering and result interpretation platforms, and related services.
Direct-to-Consumer (DTC) Genetic Testing Market Dynamics
Drivers
- Increasing Consumer Awareness
Growing public awareness of the benefits of genetic testing, including ancestry, disease risk assessment, and personalized healthcare insights, has increased the demand for DTC genetic testing. Consumers are becoming more proactive about their health and want convenient and accessible ways to obtain genetic information.
- Rising Technological Advancements
Advances in gene sequencing technology and bioinformatics have greatly reduced the cost and time required for genetic testing. Technological advancements have led to a significant reduction in the cost of genetic testing. The development of high-throughput sequencing technologies, such as next-generation sequencing (NGS), has enabled the analysis of multiple genes or even entire genomes at a fraction of the cost compared to traditional methods.
- Growing Personalized Healthcare and Wellness Trends
The rise in focus on personalized healthcare and wellness, the demand for DTC genetic testing is increasing. Consumers are increasingly interested in understanding their genetic makeup to make informed decisions about their lifestyle, disease prevention, and treatment options. DTC genetic testing provides individuals with valuable insight into their unique genetic profile, enabling a personalized health approach.
Opportunity
- Rapid Expansion of Test Offerings
DTC genetic testing companies have an opportunity to diversify their testing portfolio and expand beyond parenthood and basic health-related testing. Companies are offering a wider range of genetic tests, including pharmacogenomics, nutrigenomics and carrier screening. Companies can target a wider audience and provide more comprehensive genetic insights. This will act as an opportunity for market growth.
- Increasing Partnerships with Healthcare Providers
Continued collaboration between DTC genetic testing companies and healthcare providers creates an opportunity for a more integrated and holistic approach to genetic testing. Partnering with medical institutions, DTC companies can leverage their expertise and build trust to ensure responsible use and interpretation of genetic data.
Restraints
- Lack of Data Privacy and Ethical Concerns
The DTC genetic testing market faces challenges related to data protection and the responsible use of genetic information. Genetic testing involves the collection and analysis of personal genomic data, which raises ethical and privacy concerns. Consumers may have reservations about sharing their genetic information with companies due to potential risks of unauthorized access, data breaches, or misuse of information. These concerns can limit market growth as individuals prioritize the security and privacy of their genetic data.
Challenges
- Strict Regulatory Landscape
The DTC genetic testing market operates in a complex regulatory environment. Different countries have different regulations and guidelines regarding genetic testing, data protection and the involvement of health professionals. Adapting to changing regulatory requirements and maintaining compliance can be a significant challenge for companies operating in this market.
This direct-to-consumer (DTC) genetic testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the direct-to-consumer (DTC) genetic testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In March 2021, 23andMe announced its plans to go public through a merger with a special purpose acquisition company (SPAC) called VG Acquisition Corp. The merger aimed to accelerate the company's growth and expand its consumer health offerings
- In February 2021, MyHeritage, a leading genealogy and genetic testing company, introduced a new product called MyHeritage Health. It combined genetic testing with family history research to provide users with a comprehensive understanding of their health risks and genetic heritage.
Global Direct-to-Consumer (DTC) Genetic Testing Market Scope
The global Direct-to-Consumer (DTC) Genetic Testing Market is segmented into seven notable segments based on service, test type, technology, product type, business model, end user, and sales channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Service
- Diagnostic screening
- Prenatal
- New-born screening
- Pre-implantation diagnosis
- Relationship testing
Test Type
- Carrier testing
- Predictive testing
- Ancestry and relationship testing
- Nutrigenomics testing and others
Technology
- Targeted analysis
- Single nucleotide polymorphism (SNP) chips
- Whole genome sequencing (WGS)
Product Type
- Ancestry
- Health and wellness
- Entertainment
Business Model
- Genome data bank material model
- Individual health planning model
- Comprehensive genome tests model
- Medical precision tests model
- Restricted trait tests model
End User
- Laboratories
- Blood banks
- Nursing homes
- Hospitals
- Imaging centers
- Home care
- Cosmetics
- Others
Sales Channel
- Online sales
- OTC sales
- Doctor's office
Global Direct-to-Consumer (DTC) Genetic Testing Market Regional Analysis/Insights
The global direct-to-consumer (DTC) genetic testing market is analyzed, and market size insights and trends are provided based on service, test type, technology, product type, business model, end user and sales channel.
The countries covered in this global direct-to-consumer (DTC) genetic testing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the direct-to-consumer (DTC) genetic testing market due to the shift in the outlook of consumers toward genetic testing. Furthermore, the rise in expenditure will further boost the growth of the direct-to-consumer (DTC) genetic testing market in the region during the forecast period.
Asia-Pacific is projected to observe a significant amount of growth in the direct-to-consumer (DTC) genetic testing market due to the rise in health care awareness. Moreover, the increase in disposable income is further anticipated to propel the growth of the direct-to-consumer (DTC) genetic testing market in the region in the coming years.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The direct-to-consumer (DTC) genetic testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the direct-to-consumer (DTC) genetic testing market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the direct-to-consumer (DTC) genetic testing market. The data is available for the historic period 2015-2020.
Competitive Landscape and Direct-to-consumer (DTC) Genetic Testing Market Share Analysis
The Direct-to-Consumer (DTC) Genetic Testing Market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the direct-to-consumer (DTC) genetic testing market.
Some of the major players operating in the global direct-to-consumer (DTC) genetic testing market are:
- EasyDNA (U.S.)
- Ancestry (U.S.)
- 23andMe, Inc. (U.S.)
- Color Health, Inc.(U.S.)
- Genesis HealthCare (U.S.)
- Full Genomes Corporation, Inc.(U.S.)
- Helix OpCo LLC (U.S.)
- Living DNA Ltd (U.K.)
- Mapmygenome (India)
- GenomeWeb (U.S.)
- Gene by Gene, Ltd. (U.S.)
- MyHeritage Ltd. (Israel)
- 10x Genomics (U.S.)
- Dante Labs, Inc. (U.S.)
- 24Genetics (Spain)
- Laboratory Corporation of America Holdings (U.S.)
- Myriad Genetics, Inc. (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Uniogen Oy (turkey)
SKU-